Pancreatic Cancer Research

ResearcherUniversity of ChicagoNo recent work listed

Stanley L. Liauw

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4701-2469; OpenAlex author ID A5058687400. Sources: ClinicalTrials.gov.

Their work

Papers
2 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2009: 1 trial · 2010: none · 2011: none · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses. Co-author DOI 10.21037/jgo-20-187↗
  2. Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation. Last author DOI 10.1186/1748-717x-7-156↗

Trials 1

  1. Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer Principal investigator NCT01342354↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mitchell C. Posner · 1 shared paper, 2020 · strength 0.12
  2. Hedy Lee Kindler · 1 shared paper, 2020 · strength 0.12
  3. Daniel William Golden · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.